Share class
Morningstar Rating
Bloomberg Ticker
UEGQACE LX
NAV
172.46
18.06.2026
YTD
7.34%
as of 18.06.2026
3M
4.93%
as of 18.06.2026
1Y
13.57%
as of 18.06.2026
Share Class name
麻豆社 (Lux) Key Selection SICAV - European Growth and Income (EUR) Q-acc
Overview
The actively managed fund is focused on capturing growth and income opportunities predominantly from Europe.
It invests predominantly in European equities, high yield corporate bonds and convertible bonds.
Each asset class weighting is kept at approximately one third.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
Benefits
Equities, high yield corporate bonds and convertible bonds offer a compelling combination of growth and income opportunities with favorable risk/return characteristics.
Diversification across each asset class at approximately one third reduces overall risk.
Managed by a dedicated team of experts who can draw upon 麻豆社 Asset Management's experienced European investment teams.
Risks
This fund value may fluctuate given its equity exposure and is also impacted by changes in interest rates due to its fixed income holdings. The fund focuses intentionally on European assets, which may entail additional risks and volatility. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk). This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.
Features
| Product category |
麻豆社 Asset Allocation Funds 麻豆社 European Growth and Income Fund |
| Product domicile |
Luxembourg
|
| Portfolio management |
麻豆社 Asset Management (UK) Ltd., London
|
| Fund management |
麻豆社 Asset Management (Europe) S.A., Luxembourg
|
| Custodian bank |
麻豆社 Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
麻豆社 Asset Management (UK) Limited
|
| Day of inception |
07 October 2015
|
| Currency of account |
EUR
|
| Close of financial year |
30 September
|
| SFDR Classification |
Art.6
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
1.03% p.a.
|
| Management fee |
0.77% p.a.
|
| Total expense ratio (TER) |
1.03% p.a.
|
| Swing pricing |
yes
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
Customized Benchmark
|
| ISIN |
LU1240794898
|
| Bloomberg Ticker |
UEGQACE LX
|
Performance and Prices
Percentage growth
as of 18 June 2026
Cumulative
| EUR(%) | |
| YTD | |
| 1M | |
| 3M | 4.93 |
| 6M | 8.15 |
| 1Y | 13.57 |
| 2Y | 24.05 |
| 3Y | 35.14 |
| 5Y | |
| ø p.a.5Y | 5.20 |
Discrete Annual
| EUR(%) | |
| Q1 2025 to Q1 2026 | 10.05 |
| Q1 2024 to Q1 2025 | 7.19 |
| Q1 2023 to Q1 2024 | 9.89 |
| Q1 2022 to Q1 2023 | -3.32 |
| Q1 2021 to Q1 2022 | -0.39 |
Current data
| Net asset value | 18.06.2026 | EUR 172.46 |
| High - last 12 months | 17.06.2026 | EUR 172.68 |
| Low - last 12 months | 20.06.2025 | EUR 150.77 |
| Assets of the unit class in mn | 17.06.2026 | EUR 0.70 |
| Total product assets in mn | 17.06.2026 | EUR 407.46 |
| Indicative equity dividend yield (gross) | 29.05.2026 | 2.98% |
Structures
By the 10 largest equity positions (in %, as of 29 May 2026)
|
|
|
| ASML Holding NV | 1.22 |
| AstraZeneca PLC | 1.14 |
| Novartis AG | 1.10 |
| Infineon Technologies AG | 1.04 |
| Banco Bilbao Vizcaya Argentaria SA | 1.00 |
Fees
Ongoing costs p.a.
1.03%
Flat fee
0.96%
Management fee p.a.
0.77%
Max. issuing commission
4.00%
Max. redemption commission
0.00%
Distribution fee
(see info)
Distributions
No distributions. Continuous reinvestment of income.
Sales Authorisations
Literature
Agreement / Prospectus
|
Document type
|
Document Language
|
| Prospectus |
|
| Country supplement |
|
| Key Investor Information (KIID) |
|
| Past performance |
|
| Previous performance scenario |
|
Annual and semi-annual report (accounting on 30 September)
|
Document type
|
Document Language
|
| Annual report |
|
| Semi-annual report |
|
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.
